Polyclonal

Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy

Ashraf AboArafe * Promising new platform can rapidly respond to emerging infectious diseases (AETOS/BUSINESS WIRE)– SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical…